View of IMPROVING THE USE OF MYOCARDIAL CYTOPROTECTORS AS A METABOLIC THERAPY OF PATIENTS WITH DECOMPENSATED HEART FAILURE IN THE EARLY AND LATE POST-INFARCE PERIOD

Return to Article Details IMPROVING THE USE OF MYOCARDIAL CYTOPROTECTORS AS A METABOLIC THERAPY OF PATIENTS WITH DECOMPENSATED HEART FAILURE IN THE EARLY AND LATE POST-INFARCE PERIOD Download Download PDF